Palexia (Tapentadol Hydrochloride)

Tapentadol Hydrochloride, the active ingredient in Palexia, is an opioid analgesic presented as a oral medication for oral use. It is used to treat moderate to severe acute pain in adult patients when other analgesics are insufficient.

GNH USA supplies Palexia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Palexia is an opioid analgesic that acts on the central nervous system to relieve pain. It is indicated for: - Acute postoperative pain: Provides relief following surgical procedures. - Chronic musculoskeletal pain: Helps manage persistent pain from conditions such as osteoarthritis. - Cancer‑related pain: Used as part of a multimodal regimen for cancer pain management.

Tapentadol Hydrochloride may cause a range of adverse reactions.

Common Side Effects: - Nausea: Mild to moderate upset stomach. - Dizziness: Light‑headed feeling, especially when standing quickly. - Constipation: Reduced bowel movements, common with opioids. - Headache: Generalized head pain. - Somnolence: Feeling unusually sleepy. - Dry mouth: Reduced saliva production.

Serious or Rare Side Effects: - Respiratory depression: Slowed breathing that can be life‑threatening. - Severe hypotension: Marked drop in blood pressure. - Seizures: Uncontrolled electrical activity in the brain. - Anaphylaxis: Acute allergic reaction with hives, swelling, and airway compromise.

When prescribing Tapentadol Hydrochloride, clinicians should consider several safety measures. - Assess pain severity: Confirm that opioid therapy is appropriate for the patient’s level of pain. - Evaluate opioid tolerance: Determine if the patient has prior exposure to opioids. - Monitor for respiratory depression: Observe breathing, especially after dose initiation or increase. - Avoid concurrent CNS depressants: Limit use of alcohol, benzodiazepines, or other sedatives. - Educate on dependence risk: Discuss potential for misuse and proper disposal. - Store at ambient temperature: Keep below 25°C in the original packaging, protected from moisture.

Tapentadol Hydrochloride can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Benzodiazepines: Combined use can cause profound respiratory depression. - Central nervous system depressants: Concomitant use may enhance sedation and respiratory risks. - MAO inhibitors: May precipitate hypertensive crisis or serotonin syndrome.

Moderate Interactions (Monitor Closely): - Serotonergic agents: Increased risk of serotonin syndrome, especially with SSRIs or SNRIs. - CYP2D6 inhibitors: May raise tapentadol plasma levels, requiring dose adjustment. - Antihypertensives: May potentiate hypotensive effects, necessitating blood pressure monitoring.